Imatib®
Imatinib
Therapeutic action
Antineoplastic. Tyrosine kinase inhibitor
Indications
Philadelphia chromosome-positive acute lymphoblastic leukemia/ Chronic myeloid leukemia/Mastocytosis/SMD-SMP/SHE-LEC/GIST/Dermatofibrosarcoma protuberans
Presentation
Coated Tablets 100 mg and 400 mg